The Meadows: Resident Notification Failures - MS
The Meadows admitted the resident on November 4 with atrial fibrillation, a heart rhythm disorder. Her doctor prescribed Sotalol, a beta blocker that helps control irregular heartbeats but can further slow pulse rates.
The facility's administrator had established a clear protocol in writing: "All medications requiring pulse monitoring should be monitored before the medication is given by radial pulse for one full minute. If the pulse is below 60, contact the physician for guidance prior to giving the medication."
Nurses followed this rule once. They didn't the next two times.
On November 8 at 8:00 AM, the resident's pulse measured 50 beats per minute. Nurses correctly held the medication and did not administer it.
Thirteen hours later, at 9:00 PM, her pulse registered 56. This time, nurses gave her the Sotalol anyway. They signed off that they had administered the drug without calling the doctor.
The pattern repeated the next morning. At 8:00 AM on November 9, the resident's pulse was 55. Nurses again administered the Sotalol and signed the medication record, with no documentation that anyone had contacted her physician.
The Director of Nursing confirmed during a November 18 interview that the medication should never have been given when the resident's pulse dropped below 60. She explained that Sotalol, as a beta blocker, "can lower the pulse even more and cause weakness and circulatory concerns."
When inspectors asked whether the physician had been notified about the low pulse rates, the Director of Nursing reviewed the resident's records. She found no documentation that anyone had called the doctor.
The Administrator confirmed the same day that nursing staff should have contacted the provider when the pulse rate fell below 60 for further instruction.
The medication errors occurred within days of the resident's admission. She had been at The Meadows for only four days when nurses first gave her the heart drug despite her dangerously low pulse.
Federal inspectors reviewed three residents' medication monitoring records as part of their complaint investigation. Only one resident experienced the monitoring failures, but the violations occurred on consecutive medication doses.
Sotalol requires careful monitoring because it affects the heart's electrical system. The drug helps control atrial fibrillation by regulating irregular heartbeats, but it can also slow the heart rate too much. When a patient's pulse drops below normal ranges, continuing the medication without medical oversight can worsen circulation problems and cause weakness.
The facility's written policy acknowledged these risks by requiring pulse checks before every dose and physician consultation for low readings. Nurses measured the resident's pulse correctly each time but made independent decisions to override the safety protocol.
The medication record showed nurses took the required one-minute radial pulse measurements. They documented the low readings of 56 and 55 beats per minute. But they signed off on administering the Sotalol both times without the mandatory physician notification.
No documentation exists showing what medical guidance the resident's doctor might have provided if contacted. The physician could have adjusted the dosage, changed the timing, or temporarily discontinued the medication until the pulse rate stabilized.
The Director of Nursing's acknowledgment that beta blockers "can lower the pulse even more" highlighted the compounding risk. Each unauthorized dose potentially drove the resident's heart rate lower, creating a cycle where the medication designed to help her heart rhythm instead threatened her circulation.
The resident remained at The Meadows during the inspection, two weeks after the medication monitoring failures. Inspectors found the violations represented minimal harm or potential for actual harm, affecting few residents.
But the case illustrated how quickly safety protocols can break down for vulnerable patients requiring careful medication management. The resident's pulse had dropped to dangerous levels within her first week at the facility, and nurses made critical decisions without medical supervision on two consecutive doses.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for The Meadows from 2025-11-18 including all violations, facility responses, and corrective action plans.
Additional Resources
Data source: Official federal inspection data from the Centers for Medicare & Medicaid Services (CMS).
Editorial process: AI-synthesized regulatory data, reviewed for accuracy by our editorial team.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: June 20, 2026 · Our methodology
THE MEADOWS in FULTON, MS was cited for violations during a health inspection on November 18, 2025.
The Meadows admitted the resident on November 4 with atrial fibrillation, a heart rhythm disorder.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.